Cold Plasma Effects on Dental Implant Stability
Clinical Evaluation of Cold Plasma Surface Activation Using Different Plasma Systems on Early Implant Stability: A Randomized Controlled Within-Patient Trial
1 other identifier
interventional
11
1 country
1
Brief Summary
Cold plasma-mediated implant surface activation may reverse the biological aging of titanium by enhancing hydrophilicity and cellular response. The aim of this study was to clinically compare the effects of three different cold plasma systems on the stability of dental implants. In this prospective randomized controlled split-mouth study, a total of 44 implants were placed in 11 patients. In each patient, four implants were randomly allocated to one of the following groups: control, vacuum plasma, argon jet plasma, and cold atmospheric plasma. All implants were placed using a single-stage protocol with a minimum insertion torque of 45 Ncm. Implant stability was assessed using resonance frequency analysis (ISQ values) immediately after placement and at 2, 4, and 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2025
CompletedFirst Submitted
Initial submission to the registry
December 11, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedApril 30, 2026
December 1, 2025
4 months
December 11, 2025
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of Implant Stability
The primary outcome measure was implant stability, quantified using Implant Stability Quotient (ISQ) values obtained by resonance frequency analysis (RFA). Changes in mean ISQ values were assessed at four predefined time points across four different implant surface treatment groups. The secondary outcome measure was the early stability pattern, evaluated based on serial ISQ measurements recorded during the first 8 weeks following implant placement.
Measurements were performed at four different time points: • Immediately after placement (baseline), • 2 weeks, • 4 weeks, • 8 weeks.
Study Arms (4)
Control Arm
ACTIVE COMPARATORThe implant was inserted without the application of any supplementary surface modification.
Vacuum Plasma Application
EXPERIMENTALThe implant was placed into a sterile low-pressure plasma chamber (5-10 Torr) and exposed to non-thermal low-pressure cold plasma for 60 seconds prior to placement.
Argon Jet Plasma Application
EXPERIMENTALA portable atmospheric argon plasma jet was applied circumferentially to the implant surface for 60 seconds while the implant was rotated in a sterile holder.
Cold Atmospheric Plasma (CAP) Application
EXPERIMENTALCold plasma generated at atmospheric pressure using ambient air was applied circumferentially to the implant surface for 60 seconds while the implant was rotated in a sterile holder.
Interventions
The dental implant was placed without any plasma application.
The dental implant was placed with non-thermal low-pressure cold plasma application
The dental implant was placed with argon jet plasma application
The dental implant was placed with cold atmospheric plasma application
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Presence of edentulous areas requiring ≥4 implants for fixed prosthetic rehabilitation.
- Good or moderate oral hygiene.
- Adequate patient compliance to attend all follow-up appointments.
- Willingness to voluntarily participate in the study.
You may not qualify if:
- Refusal to participate.
- Need for alveolar ridge augmentation.
- Systemic conditions that may impair healing (e.g., uncontrolled diabetes, immunodeficiency, ongoing chemotherapy or radiotherapy, history of head-and-neck radiotherapy, substance or alcohol abuse).
- Untreated periodontal disease.
- Heavy smoking (\>10 cigarettes/day).
- Age \< 18 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaras Sutcu Imam University, Faculty of Dentistry
Kahramanmaraş, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 11, 2025
First Posted
January 16, 2026
Study Start
February 24, 2025
Primary Completion
July 8, 2025
Study Completion
September 9, 2025
Last Updated
April 30, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share